COSEL Launches New Compact 2”x3” Power Supply Series for Demanding Medical Applications

COSEL Co, Ltd today announced the expansion of its medical power offering with the addition of the new UMA series, the first two models being the 30W UMA30F and the 60W UMA60F. Both models feature a universal input range of 85 to 264VAC and comply with international safety standards. Designed for demanding medical applications, the UMA series is suitable for Body Floating (BF) applications and complies with 2MOPP (IN/OUT) and 1MOPP (OUT/FG) safety requirement. Based on a robust platform, the units’ design has been optimized to offer a very good price/performance ratio for medical applications requiring a high quality power solution. The UMA series is available in up to five output voltages of 5, 12, 15, 24, and 48VDC.

Medical applications are requiring robust and highly reliable power supplies that are able to operate around the world and comply with safety regulations. Based on many years of expertise, COSEL power designers developed an optimized flyback topology platform to offer an excellent price/performance ratio without compromising on quality and reliability. The UMA series can be operated within a universal Input range of 85 to 264VAC, and has a typical efficiency up to 91% at high line.

Currently four single output voltages are available as standard for the UMA30F: 5V/3A, 12V/2.5A, 24V/1.3A and 48V/0.65A, and five for the UMA60F: 5V/6A, 12V/4.5A, 15V/3.5A, 24V/2.5A and 48V/1.25A. Output is factory adjusted to a fixed value, but in applications where output voltage adjustment is required an option ‘Y’ with potentiometer is available.

The UMA series includes inrush current limiting circuitry, overcurrent, and overvoltage protection. Exhibiting versatility and robustness, the power supplies can be operated in an environmental temperature range of -20 to +70 degrees centigrade. Depending on the final equipment assembly style and cooling conditions, a derating may apply.

With its medical focus, the UMA series’ input to output isolation complies with 2MOPP, its input to Frame Ground (FG) complies with 1MOPP, and output to FG with 1MOPP. The units are approved in accordance with ANSI/AAMI ES60601-1 and EN60601-1 3rd Edition. In the case of Body Floating applications where patient leakage current must be less than 100 µA, with its 75 µA figure the UMA series is well below that limit and so eminently suitable for such applications.

The UMA series meets the following agency approvals: ANSI/AAMI ES60601-1, EN60601-1 3rd, C-UL (equivalent to CAN/CSA-C22.2 No.60601-1), UL62368-1, EN62368-1, C-UL (equivalent to CAN/CSA-C22.2 No.62368-1) and complies with EN60335-1.

To accommodate application specific requirements, three options are available including adjustable output voltage (Y), terminal block (T), and for applications requiring additional safety the UMA30F and UMA60F are available with reinforced isolation in conformance with the IEC class II (E).

The UMA30F measures 50.8 x 21.7 x 76.2mm [2.0 x 0.85 x 3.0 inches] (W x H x D) and weighs 80g max. The UMA60F is just 2.5mm taller (24.2mm) and weighs 120g max.

The UMA series has an excellent five-year warranty and conforms to the European RoHS and Low Voltage Directives.

The combination of small size, excellent cost/performance ratio, and high quality makes the UMA series an ideal power solution for demanding applications not only in the medical market but also for test and measurement, and industrial applications including household and similar electrical appliances.

SourceCOSEL

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”